Skip to main content
Study

An initiative to reduce insulin-related adverse drug events in a children's hospital.

Lawson SA, Hornung LN, Lawrence M, et al. An initiative to reduce insulin-related adverse drug events in a children's hospital. Pediatrics. 2022;149(1):e2020004937. doi: 10.1542/peds.2020-004937.

Save
Print
February 16, 2022
Lawson SA, Hornung LN, Lawrence M, et al. Pediatrics. 2022;149(1):e2020004937.

Insulin is a high-risk medication and can contribute to adverse events in pediatric patients. This paper describes one children’s hospital’s experience implementing a new standardized medication administration process for insulin and the impact on insulin-related adverse drug events (ADEs). Findings indicate that implementation of a PRN (i.e., “as needed”) ordering process and clinician education decreased insulin-related ADEs and reduced the time between blood glucose checks and insulin administration.

Save
Print
Cite
Citation

Lawson SA, Hornung LN, Lawrence M, et al. An initiative to reduce insulin-related adverse drug events in a children's hospital. Pediatrics. 2022;149(1):e2020004937. doi: 10.1542/peds.2020-004937.